MiroBio are an Oxford start-up developing novel therapeutics based on deep expertise in immune cell regulation based at the BioEscalator. They have just launched with £27m Series A funding.
See: http://www.mirobio.com/news-and-events/2019/MiroBio_fundraise_press_release_oct_2019.pdf